Goldman Sachs Group »

Neumora Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $10M 592k 17.05
2023-09-30 $1.0M 74k 14.11

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Ishares Tr CMN (IWM)
Amazon CMN (AMZN)
Nvidia Corporation CMN (NVDA)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IVV)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Meta Platforms CMN (META)
Vanguard Index Fds CMN (VOO)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Neumora Therapeutics

Softbank Group Corp
MIC Capital Management UK
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Artal Group
EcoR1 Capital
Avidity Partners Management
Citadel Advisors
Hillhouse Capital Advisors
OrbiMed Advisors
Goldman Sachs Group
Logos Global Management
Vanguard Group
Addis & Hill
Schonfeld Strategic Advisors
Pier Capital

View all funds holding Neumora Therapeutics